Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that help ease the treatment of chronic disorders such as diabetes, cancer, chronic pain among others. Following are a few recent developments in the North America infusion devices market.
- In April 2024, Mackenzie Health launched a technology in Canada that allows for two-way information flow between an intravenous (IV) medication pump and a patient’s electronic medical record. The technology, known as BD Alaris EMR Interoperability, eliminates the need for healthcare professionals to manually program pumps. It sends infusion safety information back to Epic EMR, reducing the risk of administration errors and providing an accurate infusion record in the EMR.
- In November 2022, Medtronic plc announced the launch of Medtronic Extended infusion set in the US. It is the first and only infusion set labeled for up to seven-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and usually needs to be changed every two to three days.
- In May 2022, Fresenius Kabi acquired Ivenix and its advanced infusion pump technology, expanding its portfolio of advanced infusion pumps and solutions for healthcare professionals to address healthcare needs across the care continuum. Fresenius Kabi also announced that it has rapidly expanded its infusion therapy portfolio in the US, obtaining FDA approvals for multiple IV solutions in anticipation of qualifying its North Carolina manufacturing site to supply the US customers with IV solutions.
- In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021.
An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.
Growing Geriatric Population Drives North America Infusion Devices Market Growth
According to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23%. According to Statistics Canada, in 2022, almost one in five Canadians (18.8% of the population; 7,329,910 people) were at least 65 years of age. Almost 20% of the Canadian population is aged 65 years and above. Furthermore, population projections suggest that 21 to 29% of Canadians could be aged 65 or above by 2068.
A few key benefits of infusion therapy used for senior populations are listed below.
• Rehydration and Electrolyte Balance: Dehydration can be a higher risk for seniors due to factors such as decreased thirst, certain medications, and changes in kidney function. IV fluids can help seniors maintain the necessary hydration and electrolyte levels for overall health.
• Improved Nutritional Status: Aging makes it harder for human bodies to consume the right nutrients, increasing the risk of chronic illnesses. Infusion therapy provides a direct way for seniors to get essential minerals, vitamins, and amino acids efficiently.
• Enhanced Immune Function: Seniors’ immune systems may need extra support, as they are more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.
• Pain Management: Many seniors deal with chronic pain daily, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, providing relief and reducing inflammation.
Thus, the increasing geriatric population drives the demand for infusion devices across North America.
North America Infusion Devices Market: Competitive Landscape and Key Developments
Becton Dickinson and Co, Fresenius Kabi AG, B Braun SE, CODAN US Corp, Baxter International Inc., Elimedical Inc., ICU Medical Inc., BPL Medical Technologies Pvt Ltd, Nipro Corp., KD Scientific Inc., Medtronic Plc, Zimed Healthcare Ltd, Terumo Corp., Eitan Medical Ltd, Polymedicure, and Moog Inc are a few key companies operating in the market. These companies focus on product innovation strategies to meet evolving customer demands, along with maintaining their brand name in the North America Infusion Devices market. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the surging demand from consumers worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.
A few Developments in the North America Infusion Devices market are as follows:
- Moog Inc. received US FDA 510(k) clearance for CURLIN 8000 Ambulatory Infusion System. This premium infusion platform was developed specifically for use in home infusion settings. The CURLIN 8000 combines a reliable and robust design with a simple, intuitive user interface designed for easy navigation by both clinical and nonclinical users. The CURLIN 8000 also integrates seamlessly with CURLIN RxManager, a completely new medication safety software developed to complement existing home infusion workflows. (Source: Moog Inc., Press Release, May 2024)
- Eitan Medical launched its new cutting-edge, connected infusion multi-therapy ambulatory infusion system—Avoset. The connected Avoset Infusion System is designed to transform post-acute care and specialty infusion therapy with compact and simplified technology that can monitor infusion treatment data remotely, subsequently improving patient safety and user experience. (Source: Eitan Medical, Press Release, April 2023).
